D
Defence Therapeutics Inc
CNSX:DTC
Defence Therapeutics Inc
CNSX:DTC
Price:
0.53
CAD
-3.64%
Market Closed
Market Cap:
CA$30.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
D
|
Defence Therapeutics Inc
CNSX:DTC
|
CA |
|
N
|
New City Development Group Ltd
HKEX:456
|
HK |
Balance Sheet
Balance Sheet Decomposition
Defence Therapeutics Inc
Defence Therapeutics Inc
Balance Sheet Decomposition is not available for
Defence Therapeutics Inc
Defence Therapeutics Inc
Balance Sheet
Defence Therapeutics Inc
Defence Therapeutics Inc
Currency: CAD
| Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | Jun-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
0
|
2
|
5
|
1
|
3
|
0
|
1
|
|
| Cash |
0
|
2
|
5
|
1
|
3
|
0
|
1
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
2
|
6
|
1
|
3
|
0
|
1
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
2
+24 413%
|
6
+193%
|
1
-87%
|
4
+391%
|
0
-86%
|
2
+246%
|
|
| Liabilities | ||||||||
| Accounts Payable |
0
|
0
|
0
|
1
|
0
|
2
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
2
|
0
|
|
| Total Current Liabilities |
0
|
0
|
0
|
1
|
0
|
4
|
3
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
2
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
+519%
|
0
+153%
|
1
+805%
|
2
+78%
|
4
+107%
|
3
-28%
|
|
| Equity | ||||||||
| Common Stock |
0
|
2
|
8
|
9
|
17
|
19
|
24
|
|
| Retained Earnings |
0
|
1
|
2
|
10
|
16
|
23
|
26
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
2
N/A
|
5
+194%
|
0
N/A
|
2
N/A
|
4
N/A
|
1
+65%
|
|
| Total Liabilities & Equity |
0
N/A
|
2
+24 413%
|
6
+193%
|
1
-87%
|
4
+391%
|
0
-86%
|
2
+246%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
35
|
35
|
35
|
37
|
44
|
46
|
55
|
|
Switch to:
Switch to:
See Also
Discover More
